NCT01998256View on ClinicalTrials.gov

Clinical Benefit of Rigourous AV Delay Optimization in Patients With a Dual Chamber Pacemaker

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Quality of LifePacemaker Ddd PermanentAtrial Dysfunction
Interventions
DEVICE

AV optimization

Iterative DFT (diastolic filling time) method for AV optimization. Optimal AV delay for both atrial sensed and atrial paced settings was defined by two experienced echocardiographists, after 3 separate measurements.

Trial Locations (1)

3500

Jessa Hospital, Hasselt

All Listed Sponsors
lead

Jessa Hospital

OTHER

NCT01998256 - Clinical Benefit of Rigourous AV Delay Optimization in Patients With a Dual Chamber Pacemaker | Biotech Hunter | Biotech Hunter